相关实验视频
Updated: Jan 17, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
阿特里·金在一个82岁的老人身上诱导了库辛综合征
Suyoung Choi, Christopher Youn, Vivian Yang
1Department of Dermatology, Stanford University School of Medicine, Stanford, California, United States. gbae@stanford.edu.
一位老年人服用关节疼痛补充剂后出现了库辛综合征的症状. 这凸显了不受监管的场外产品的风险,以及需要更好的补充监管.
科学领域:
- 内分泌学 在内分泌学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 库希综合征是一种由长期暴露于高皮质醇水平引起的荷尔蒙障碍.
- 非处方药的补充剂可能含有未公开的成分,具有强大的药理作用.
- 食补充剂经常绕过处方药所需的严格的食品和药物管理局 (FDA) 批准程序.
研究的目的:
- 报告因非处方药补充剂引起的阳性化库希综合征病例.
- 要突出与补充剂外源性皮质类固醇暴露相关的皮肤学表现.
- 强调不受监管的食补充剂的潜在危害.
主要方法:
- 一个82岁的男性患者的病例报告,呈现出紫色斑点和暗示库辛综合征的症状.
- 审查患者的药物和补充史,包括阿特里金的消费.
- 实验室调查,包括测量德克萨米他后皮质醇水平.
主要成果:
- 患者表现出皮肤病症状,包括紫色斑点,,皮肤薄,中心肥胖.
- 德克萨米他后皮质醇水平升高表明库辛综合征.
- 疑似原因是阿特里金,这是一种含有模仿皮质类固醇的未公开成分的补充剂.
结论:
- 关节疼痛补充剂Artri King可以诱导阴性库希综合征和相关的皮肤问题.
- 这一案例强调了不受监管的非处方药补充剂所带来的重大健康风险.
- 迫切需要提高饮食补充剂的透明度和监管监督.
更多相关视频
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care